Pelthos Therapeutics (PTHS) Asset Utilization Ratio (2026)

Pelthos Therapeutics (PTHS) Asset Utilization Ratio (2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	138.71 Bn	130.86 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.60 Bn	77.60 Bn	3.93 Bn	0.38
3	Argenx Se	64.82 Bn	59.63 Bn	1.37 Bn	-
4	Moderna	57.92 Bn	52.79 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.88 Bn	36.78 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.46 Bn	28.15 Bn	992.69 Mn	0.90
7	BioNTech SE	27.96 Bn	9.57 Bn	668.28 Mn	0.13
8	Insmed	27.35 Bn	26.19 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.13
10	Pelthos Therapeutics	92.20 Mn	67.64 Mn	21.23 Mn	0.38

Download Data

Date	Value
Jun 30, 2026	0.32